Investing Profile

Greg Yap

InvestorVC
Partner at Menlo Ventures
menlovc.com/greg-yapPalo Alto, California
Photo of Greg Yap, Partner at Menlo Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
GE Network
32 CONNECTIONS
The Aspen Institute Network
29 CONNECTIONS
Menlo Ventures Network
20 CONNECTIONS
cb
$8.0M - $15.0M
$12.0M
36
$500M
CompanyStageDateRound SizeTotal Raised
Aurora Therapeutics
SeedJan 2026$16M
$16M
Chai Discovery
Series BDec 2025$130M
Series AAug 2025$70M
$230M
Co-investors: Hemant Taneja (General Catalyst), Fred Ehrsam (Paradigm), Lachy Groom (Stripe), Annie Lamont (Oak HC/FT), Nitesh Banta (Stellar Capital)
Cartwheel
Series BAug 2025$35M
Series ASep 2023$20M
$75M
Co-investors: Daniel Levine (Accel), Holly Maloney McConnell (General Catalyst), Minnie Ingersoll (TenOneTen Ventures), Craig Cummings (Moonshots Capital), Lainy Painter (Craft Ventures), Sean Whitney (Craft Ventures), Elena (Lainy) Painter (Craft Ventures), Reva Nohria (General Catalyst Partners), Raoul Maier (Eudemian Ventures, LLC), Samara Hernandez (Chingona Ventures), Akshay Kothari, Drew Houston
Heidi Health
Series AMar 2025$17M
$88M
Co-investors: Brian Keil (Alumni Ventures ), Taylor Brandt (Headline (formerly e.ventures)), Sri Chandrasekar (Point72 Ventures), Michael Tolo (Blackbird Ventures Australia)
Clear Labs
Series DJan 2025$30M
Series CMay 2021$60M
Series UnknownMay 2020$21M
Series BOct 2018$21M
$170M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Aydin Senkut (Felicis Ventures), Chris Sklarin (Alumni Ventures ), Kyle Kurpinski (Tencent Holdings)
Vilya
Series AJun 2024$21M
$71M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Xaira Therapeutics
Series AApr 2024$1B
$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Roelof Botha (Sequoia Capital), Vikram Bajaj (Foresite Capital), Robert Nelsen (ARCH Venture Partners)
Delfi Diagnostics
Series BJul 2022$230M
Series AJan 2021$100M
SeedAug 2019$6M
$330M
Co-investors: Rishi Gupta (OrbiMed), Justin Kao (DFJ Growth)
Investor Xaira Therapeutics2024 - Present
Board Member & Investor Cartwheel2023 - Present
Board Member & Investor Vilya2023 - Present
Board Member & Investor Koala Health2022 - Present
Board Member & Investor Ophelia2021 - Present
Investor Scribe Therapeutics2021 - Present
Board Observer & Investor Genesis Therapeutics2020 - Present
Board Member & Investor H12020 - Present
Board Member & Investor Particle Health2020 - Present
Health Innovators Fellow The Aspen Institute2019 - Present
Board Member & Investor Delfi Diagnostics2019 - Present
Board Member & Investor Riva Health2019 - Present
Investor Encoded Therapeutics Inc.2019 - Present
Investor Benchling2019 - Present
Board Member & Investor Clear Labs2019 - Present
Investor Pliant Therapeutics2018 - Present
Board Member & Investor Epiodyne2018 - Present
Partner Menlo Ventures2017 - Present
Investor Recursion2017 - Present
Board Member Outward Bound California2013 - Present
CEO & Co-founder PyrAmes2016 - 2017
Entrepreneur in Residence Illumina Ventures2016 - 2017
CEO & Co-founder Biodesy (now BlueLight Therapeutics, Inc.)2013 - 2016
Entrepreneur in Residence GE2013 - 2013
Lifecycle Leader (SVP), Advanced Assays Roche Diagnostics2010 - 2013
Lifecycle Leader (SVP), Advanced Assays Ventana Medical Systems2010 - 2013
Chief Operating Officer CellPoint Diagnostics2008 - 2009
Vice President, Molecular Diagnostics Affymetrix2006 - 2008
Vice President, DNA Products Affymetrix2001 - 2005
Director, Business Development Affymetrix1997 - 1999
Business Analyst McKinsey1995 - 1997